Hypoglycaemia in Type 2 diabetes
Open accessAbstract
The primary cause of hypoglycaemia in Type 2 diabetes is diabetes medication—in particular, those which raise insulin levels independently of blood glucose, such as sulphonylureas (SUs) and exogenous insulin. The risk of hypoglycaemia is increased in older patients, those with longer diabetes duration, lesser insulin reserve and perhaps in the drive for strict glycaemic control. Differing definitions, data collection methods, drug type/regimen and patient populations make comparing rates of hypoglycaemia difficult. It is clear that patients taking insulin have the highest rates of self‐reported severe hypoglycaemia (25% in patients who have been taking insulin for > 5 years). SUs are associated with significantly lower rates of severe hypoglycaemia. However, large numbers of patients take SUs in the UK, and it is estimated that each year > 5000 patients will experience a severe event caused by their SU therapy which will require emergency intervention. Hypoglycaemia has substantial clinical impact, in terms of mortality, morbidity and quality of life. The cost implications of severe episodes—both direct hospital costs and indirect costs—are considerable: it is estimated that each hospital admission for severe hypoglycaemia costs around £1000. Hypoglycaemia and fear of hypoglycaemia limit the ability of current diabetes medications to achieve and maintain optimal levels of glycaemic control. Newer therapies, which focus on the incretin axis, may carry a lower risk of hypoglycaemia. Their use, and more prudent use of older therapies with low risk of hypoglycaemia, may help patients achieve improved glucose control for longer, and reduce the risk of diabetic complications.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Plasma glucose ≤3.9 mmol/l (70 mg/dl) sometimes occurs in non-diabetic people, especially women and children, though usually during prolonged fasting.
“plasma glucose concentrations ≤3.9 mmol/l (70 mg/dl) sometimes occur in non-diabetic individuals [1,3].This is true, particularly in women and children, albeit generally during prolonged fasting.”
From Preventing hypoglycaemia: what is the appropriate glucose alert value? (2009) · cites this paper as [3]
Amiel et al. recommended a therapeutic plasma glucose lower limit of 4.0-4.5 mmol/l (72-81 mg/dl).
“they recommend a therapeutic plasma glucose concentration lower limit of 4.0-4.5 mmol/l (72-81 mg/dl).”
From Preventing hypoglycaemia: what is the appropriate glucose alert value? (2009) · cites this paper as [3]
Amiel et al. also proposed a value of 3.5 mmol/l (63 mg/dl).
“Amiel et al. [3] also suggest a value of 3.5 mmol/l (63 mg/dl).”
From Preventing hypoglycaemia: what is the appropriate glucose alert value? (2009) · cites this paper as [3]
Maintaining glycaemic control in patients is no easy task, as hypo- or hyperglycaemia can result from administration of the currently available treatments.
“However, maintaining glycaemic control in patients is no easy task, as hypo- or hyperglycaemia can result from administration of the currently available treatments resulting in either too much or not enough, respectively, of an anti-hyperglycaemic effect.3,48”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · see citing works
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419 · see citing works
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129 · see citing works
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962 · see citing works
DeFronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1092 · Cited by 1,559 · see citing works
Buse, J. B., Henry, R. R., Han, J., Kim, D. D., Fineman, M. S., Baron, A. D., & for the Exenatide-113 Clinical Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2628 · Cited by 1,346 · see citing works
Kendall, D. M., Riddle, M. C., Rosenstock, J., Zhuang, D., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1083 · Cited by 1,177 · see citing works
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160 · see citing works
Defining and Reporting Hypoglycemia in Diabetes
American Diabetes Association Workgroup on Hypoglycemia (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1245 · Cited by 1,146 · see citing works
Nauck, M. A., Kleine, N., �rskov, C., Holst, J. J., Willms, B., & Creutzfeldt, W. (1993) · Diabetologia · doi:10.1007/bf00401145 · Cited by 1,092 · see citing works
Aschner, P. J., Kipnes, M. S., Lunceford, J. K., Sanchez, M., Mickel, C., Williams‐Herman, D., & for the Sitagliptin Study 021 Group (2006) · Diabetes Care · doi:10.2337/dc06-0703 · Cited by 878 · see citing works
Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
UK Hypoglycaemia Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0599-y · Cited by 825 · see citing works
Charbonnel, B., Karasik, A., Liu, J., Wu, M., Meininger, G., & for the Sitagliptin Study 020 Group (2006) · Diabetes Care · doi:10.2337/dc06-0706 · Cited by 790 · see citing works
Resistance to Insulin Therapy Among Patients and Providers
Peyrot, M. F., Rubin, R. R., Lauritzen, T., Skovlund, S. E., Snoek, F. J., Matthews, D. R., Landgraf, R., Kleinebreil, L., & Panel, O. B. O. T. I. D. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2673 · Cited by 783 · see citing works
Nauck, M. A., Meininger, G. E., Sheng, D., Terranella, L., Stein, P. P., & Sitagliptin Study 024 Group (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00704.x · Cited by 656 · see citing works
Fear of hypoglycemia: quantification, validation, and utilization
Cox, D. J., Irvine, A., Gonder-Frederick, L., Nowacek, G., & Butterfield, J. (1987) · Diabetes Care · doi:10.2337/diacare.10.5.617 · Cited by 579 · see citing works
Frequency of Severe Hypoglycemia Requiring Emergency Treatment in Type 1 and Type 2 Diabetes
Leese, G. P., Wang, J., Broomhall, J., Kelly, P., Marsden, A., Morrison, W., Frier, B. M., Morris, A. D., & For the DARTS/MEMO Collaboration (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1176 · Cited by 559 · see citing works
Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas
Shorr, R. I. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360095010 · Cited by 459 · see citing works
Insulin glargine or NPH combined with metformin in type 2 diabetes: The LANMET study
Yki-Järvinen, H., Kauppinen-Mäkelin, R., Tiikkainen, M., Vähätalo, M., Virtamo, H., Nikkilä, K., Tulokas, T., Hulme, S., Hardy, K., McNulty, S., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0132-0 · Cited by 434 · see citing works
Yki-Järvinen, H., Ryysy, L., Nikkilä, K., Tulokas, T., Vanamo, R., & Heikkilä, M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-5-199903020-00002 · Cited by 433 · see citing works
Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes.
Cranston, I., Lomas, J., Amiel, S. A., Maran, A., & Macdonald, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91336-6 · Cited by 430 · see citing works
Self-citationMehta, Z., Cull, C., STRATTON, I. M., Yudkin, J. S., Jenkinson, C., Fletcher, A., Battersby, C., Holman, R. R., & Turner, R. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1125 · Cited by 428 · see citing works
Hypoglycemia in patients with type 2 diabetes mellitus
Miller, C. D., Phillips, L. S., Ziemer, D. C., Gallina, D. L., Cook, C. B., & El-Kebbi, I. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1653 · Cited by 341 · see citing works
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Segel, S. A., Paramore, D. S., & Cryer, P. E. (2002) · Diabetes · doi:10.2337/diabetes.51.3.724 · Cited by 337 · see citing works
Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus
Yki-Järvinen, H., Kauppila, M., Kujansuu, E., Lahti, J., Marjanen, T., Niskanen, L., Rajala, S., Ryysy, L., Salo, S., Seppälä, P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272005 · Cited by 324 · see citing works
Improvement of Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes
Davies, M., Storms, F., Shutler, S., Bianchi-Biscay, M., Gomis, R., & for the AT.LANTUS Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1282 · Cited by 314 · see citing works
Hypoglycaemia in insulin‐treated Type 2 diabetes: frequency, symptoms and impaired awareness
Henderson, J. N., Allen, K. V., Deary, I. J., & Frier, B. M. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01072.x · Cited by 287 · see citing works
Garber, A. J., Schweizer, A., Baron, M. A., Rochotte, E., & Dejager, S. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00684.x · Cited by 268 · see citing works
Holstein, A., Plaschke, A., & Egberts, E. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.235 · Cited by 264 · see citing works
Rosenstock, J., Kim, S. W., Baron, M. A., Camisasca, R. ‐., Cressier, F., Couturier, A., & Dejager, S. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00698.x · Cited by 255 · see citing works
Moses, R. G., Slobodniuk, R., BOYAGES, S. C., Colagiuri, S., Kidson, W., Carter, J., Donnelly, T., Moffitt, P. S., & Hopkins, H. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.119 · Cited by 246 · see citing works
(1976) · PubMed · Cited by 244 · see citing works
Sosnowski, C., & Janeczko-Sosnowska, E. (2007) · PubMed · Cited by 234 · see citing works
Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes
Davis, R. E., Morrissey, M., Peters, J. R., Wittrup-Jensen, K., Kennedy-Martin, T., & Currie, C. J. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x61929 · Cited by 218 · see citing works
Rates of hypoglycemia in users of sulfonylureas
Van Staa, T., Abenhaim, L., & Monette, J. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00024-3 · Cited by 211 · see citing works
Assessment of the Impact of Fear of Hypoglycemic Episodes on Glycemic and Hypoglycemia Management
Leiter, L. A., Yale, J., Chiasson, J., Harris, S. B., & Kleinstiver, P. W. (2005) · Cited by 202 · see citing works
Drug-Induced Hypoglycemic Coma in 102 Diabetic Patients
Ben-Ami, H., Nagachandran, P., Mendelson, A., & Edoute, Y. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.3.281 · Cited by 201 · see citing works
Altered Hierarchy of Protective Responses Against Severe Hypoglycemia in Normal Aging in Healthy Men
Matyka, K., Evans, M., Lomas, J., Cranston, I., Macdonald, I., & Amiel, S. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.2.135 · Cited by 195 · see citing works
Self-citationThe economic and quality of life impact of hypoglycemia
Lundkvist, J., Berne, C., Bolinder, B., & Jönsson, L. (2005) · The European Journal of Health Economics · doi:10.1007/s10198-005-0276-3 · Cited by 163 · see citing works
Wright, A. D., Cull, C. A., Macleod, K. M., & Holman, R. R. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.08.010 · Cited by 153 · see citing works
The place of sulfonylureas in the therapy for type 2 diabetes mellitus
Prato, S. D., & Pulizzi, N. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.003 · Cited by 149 · see citing works
Hypoglycemia as a barrier to glycemic control
Davis, S. N., & Alonso, M. D. (2004) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(03)00058-8 · Cited by 143 · see citing works
Perceived symptoms of hypoglycaemia in elderly Type 2 diabetic patients treated with insulin
Jaap, A. J., Jones, G. C., McCrimmon, R. J., Deary, I. J., & Frier, B. M. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199805)15:5 · Cited by 134 · see citing works
Stahl, M., & Berger, W. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00110.x · Cited by 125 · see citing works
Clinical Characterisation of Severe Hypoglycaemia
Holstein, A., Plaschke, A., & Egberts, E. ‐. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-42728 · Cited by 119 · see citing works
New blindness in diabetes reduced by more than one-third in Stockholm County
Bäcklund, L. B., Algvere, P. V., & Rosenqvist, U. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199709)14:9 · Cited by 118 · see citing works
Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes.
Fanelli, C. G., Paramore, D. S., Hershey, T. G., Terkamp, C., Ovalle, F., Craft, S., & Cryer, P. E. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1920 · Cited by 117 · see citing works
Glibenclamide vs Gliclazide in Type 2 Diabetes of the Elderly
Tessier, D., Dawson, K., Tétrault, J. P., Bravo, G., & Meneilly, G. S. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00256.x · Cited by 116 · see citing works
Acarbose in the treatment of elderly patients with type 2 diabetes
Josse, R. G., Chiasson, J.-L., Ryan, E. A., Lau, D. C. W., Ross, S. A., Yale, J.-F., Leiter, L. A., Maheux, P., Tessier, D., Wolever, T. M. S., et al. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00176-6 · Cited by 110 · see citing works
Maran, A., Lomas, J., Macdonald, I. A., & Amiel, S. A. (1995) · Diabetologia · doi:10.1007/bf00400601 · Cited by 102 · see citing works
Self-citationUK prospective study of therapies of maturity-onset diabetes
Turner, R. C., Mann, J. I., Iceton, G., Oakes, S., Smith, A., Moore, J., Hockaday, T. D. R., Holman, R. R., Stowers, J., Stowers, M., et al. (1983) · Diabetologia · doi:10.1007/bf00257337 · Cited by 87 · see citing works
Metformin and the sulphonylureas: the comparative risk.
Campbell, I. W. (1985) · PubMed · Cited by 84 · see citing works
Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia
Holstein, A., Plaschke, A., Hammer, C., & Egberts, E. ‐. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0592-4 · Cited by 76 · see citing works
Incidence and Costs of Severe Hypoglycemia
Holstein, A., Plaschke, A., & Egberts, E. ‐. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2109 · Cited by 72 · see citing works
Negotiating the Barrier of Hypoglycemia in Diabetes
Cryer, P. E., & Childs, B. P. (2002) · Diabetes Spectrum · doi:10.2337/diaspect.15.1.20 · Cited by 64 · see citing works
Nattrass, M., & Lauritzen, T. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801422 · Cited by 59 · see citing works
Hypoglycemia in type 2 diabetes
Banarer, S., & Cryer, P. E. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.003 · Cited by 51 · see citing works
Peacey, S. R., Rostami‐Hodjegan, A., George, E., Tucker, G. T., & Heller, S. R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3910 · Cited by 50 · see citing works
Moses, R. G. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.7.1455 · Cited by 48 · see citing works
What do patients with diabetes know about their tablets?
Browne, D. L., Avery, L., Turner, B. C., Kerr, D. E., & Cavan, D. A. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00327.x · Cited by 46 · see citing works
Unreliability of reports of hypoglycaemia by diabetic patients
Heller, S. R., Chapman, J., McCloud, J., & Ward, J. (1995) · BMJ · doi:10.1136/bmj.310.6977.440 · Cited by 44 · see citing works
Ritholz, M. D., & Jacobson, A. M. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00243.x · Cited by 44 · see citing works
Heller, S. R. (2010) · Medicine · doi:10.1016/j.mpmed.2010.08.015 · Cited by 39 · see citing works
Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older.
Greco, D., & Angileri, G. (2004) · PubMed · Cited by 34 · see citing works
Pitale, S., Kernan-Schroeder, D., Emanuele, N., Sawin, C. T., Sacks, J. M., & Abraira, C. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.12.002 · Cited by 32 · see citing works
Holstein, A., Plaschke, A., Hammer, C., Ptak, M., Kühn, J., Kratzsch, C., Diekmann, J., Kleesiek, K., Maurer, H. H., & Egberts, E. ‐. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0697-9 · Cited by 31 · see citing works
Trovati, M., Burzacca, S., Mularoni, E., Massucco, P., Cavalot, F. L., Mattiello, L., & Anfossi, G. (1991) · Diabetologia · doi:10.1007/bf00400996 · Cited by 31 · see citing works
[Frequency and costs of hospital stays for hypoglycemia in France in 1995].
Allicar, M. P., Megas, F., Houzard, S., Baroux, A., Thai, F. L., & Augendre‐Ferrante, B. (2000) · PubMed · Cited by 28 · see citing works
Garber, A. J., Marre, M., Blonde, L., Allavoine, T., Howlett, H. C. S., Lehert, P., & Cornes, M. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00259.x · Cited by 25 · see citing works
Sotiropoulos, A., Skliros, E., Tountas, C. D., Apostolou, U., & PEPPAS, T. (2005) · Eastern Mediterranean Health Journal · doi:10.26719/2005.11.3.485 · Cited by 16 · see citing works
Doctors are failing to tell diabetic people about UK driving rules
Hitchen, L. (2006) · BMJ · doi:10.1136/bmj.332.7545.812-d · Cited by 11 · see citing works
The measurement of blood glucose and the definition of hypoglycemia.
Маркс (1976) · PubMed · Cited by 6 · see citing works
Flagged first, then by citations
3 of the 77 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Canadian Diabetes Association (CDA) Clinical Practice Guidelines Expert Committee. Hypoglycemia. Can J Diabetes 2003; 27 : S43 - S45.
- European Agency for Evaluation of Medicinal Products (EMEA). Note for guidance on clinical investigation of medicinal products in the treatment of diabetes mellitus. 2006. Available at http:// www.emea.eu.int/pdfs/human/ewp/108000en.pdf Last accessed 1 September 2007. 14645491, 2008, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/j.1464-5491.2007.02341.x, Wiley Online Library on [20/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
- Guillausseau PJ. Monitoring of metabolic control in patients with non-insulin-dependent diabetes mellitus on oral hypoglycaemic agents: value of evening blood glucose determination. Diabet Med 1997; 14: 798 -802.
- UK Hypoglycaemia Study Group. Examining hypoglycaemic risk in diabetes: effect of treatment and type of diabetes. Diabetologia 2007; 50: 1140 -1147.
- Quality of life in type 2 diabetic patients is affected by complications not by intensive policies to improve blood glucose or blood pressure control. Diabetes Care 1999; 22: 1125 -1136.
Cited by
Sorted by citations
Rodbard, H. W., Jellinger, P. S., Davidson, J. A., Einhorn, D., Garber, A. J., Grunberger, G., Handelsman, Y., Horton, E. S., Lebovitz, H., Levy, P., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.6.540 · Cited by 942 · see citing works
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623 · see citing works
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563 · see citing works
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441 · see citing works
Yaffe, K. S. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.6176 · Cited by 434 · see citing works
Miller, M. E., Bonds, D. E., Gerstein, H. C., Seaquist, E. R., Bergenstal, R. M., Calles-Escandon, J., Childress, R. D., Craven, T. E., Cuddihy, R. M., Dailey, G., et al. (2010) · BMJ · doi:10.1136/bmj.b5444 · Cited by 429 · see citing works
Gallwitz, B., Rosenstock, J., Rauch, T., Bhattacharya, S., Patel, S. D., von Eynatten, M., Dugi, K. A., & Woerle, H. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60691-6 · Cited by 339 · see citing works
Jendle, J., Nauck, M. A., Matthews, D. R., Frid, A., Hermansen, K., Düring, M., Zdravkovic, M., Strauss, B. J., Garber, A. J., & Groups, O. B. O. T. L. A. L. S. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01158.x · Cited by 312 · see citing works
Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes
Bremer, J. P., Jauch-Chara, K., Hallschmid, M., Schmid, S., & Schultes, B. (2009) · Diabetes Care · doi:10.2337/dc09-0114 · Cited by 298 · see citing works
Yapanis, M., James, S., Craig, M. E., O'Neal, D. N., & Ekinci, E. I. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac034 · Cited by 302 · see citing works
Hypoglycemia: The neglected complication
Kalra, S., Mukherjee, J. J., Venkataraman, S., Bantwal, G., Shaikh, S., Saboo, B., Das, A. K., & Ramachandran, A. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.117219 · Cited by 255 · see citing works
Bravis, V., Hui, E., Salih, S., Mehar, S., Hassanein, M. M., & Devendra, D. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02948.x · Cited by 225 · see citing works
Lactic Acidosis Induced by Metformin
Lalau, J. (2010) · Drug Safety · doi:10.2165/11536790-000000000-00000 · Cited by 221 · see citing works
Mechanisms of hypoglycemia unawareness and implications in diabetic patients
Martín-Timón, I. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i7.912 · Cited by 204 · see citing works
Matthews, D. R., Dejager, S., Åhrén, B., Fonseca, V. A., Ferrannini, E., Couturier, A., Foley, J. E., & Zinman, B. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01233.x · Cited by 198 · see citing works
Bruce, D. G., Davis, W. A., Casey, G. P., Clarnette, R. M., Brown, S. G. A., Jacobs, I. G., Almeida, O. P., & Davis, T. M. E. (2009) · Diabetologia · doi:10.1007/s00125-009-1437-1 · Cited by 202 · see citing works
Cardiovascular effects of gliptins
Scheen, A. J. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.183 · Cited by 175 · see citing works
Sarkar, U., Karter, A. J., Liu, J. Y., Moffet, H. H., Adler, N. E., & Schillinger, D. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1389-7 · Cited by 173 · see citing works
Gooßen, K., & Gräber, S. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01610.x · Cited by 167 · see citing works
Determinants of Severe Hypoglycemia Complicating Type 2 Diabetes: The Fremantle Diabetes Study
Davis, T. M. E., Brown, S. G. A., Jacobs, I. G., Bulsara, M. K., Bruce, D. G., & Davis, W. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2828 · Cited by 169 · see citing works
Arnolds, S., Dellweg, S., Clair, J., Dain, M., Nauck, M. A., Rave, K., & Kapitza, C. (2010) · Diabetes Care · doi:10.2337/dc09-2191 · Cited by 167 · see citing works
Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment
Marquard, J., Otter, S., Welters, A., Stirban, A., Fischer, A., Eglinger, J., Herebian, D., Kletke, O., Klemen, M. S., Stožer, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3822 · Cited by 161 · see citing works
Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes.
Ross, S. (2013) · American Journal of Medicine · doi:10.1016/j.amjmed.2013.06.012 · Cited by 149 · see citing works
Karter, A. J., Warton, E. M., Lipska, K. J., Ralston, J. D., Moffet, H. H., Jackson, G. G., Huang, E. S., & Miller, D. R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.3844 · Cited by 150 · see citing works
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes
Ahren, B. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s33934 · Cited by 148 · see citing works
Pharmacologic management of type 2 diabetes
Harper, W., Clement, M., Goldenberg, R., Hanna, A., Main, A., Retnakaran, R., Sherifali, D., Woo, V., & Yale, J.-F. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.021 · Cited by 138 · see citing works
Marrett, E., Radican, L., Davies, M. J., & Zhang, Q. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-251 · Cited by 133 · see citing works
Elliott, L., Fidler, C., Ditchfield, A., & Stissing, T. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0157-z · Cited by 138 · see citing works
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
Kedia (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s20633 · Cited by 135 · see citing works
Barzilai, N., Guo, H., Mahoney, E. M., Caporossi, S., Golm, G. T., Langdon, R. B., Williams‐Herman, D., Kaufman, K. D., Amatruda, J. M., Goldstein, B. J., et al. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.568059 · Cited by 130 · see citing works
Cariou, B., Fontaine, P., Eschwege, E., Lièvre, M., Gouet, D., Huet, D., Madani, S., Lavigne, S., & Charbonnel, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.10.007 · Cited by 129 · see citing works
Exercise therapy in Type 2 diabetes
Praet, S., & van Loon, L. J. C. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0129-0 · Cited by 128 · see citing works
Signorovitch, J. E., Macaulay, D., Diener, M., Yan, Y., Wu, E. Q., Gruenberger, J. ‐., & Frier, B. M. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12031 · Cited by 125 · see citing works
Hypoglycemia in Patients with Diabetes and Renal Disease
Alsahli, M., & Gerich, J. E. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4050948 · Cited by 123 · see citing works
Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners
Ajjan, R., Slattery, D., & Wright, E. E. (2019) · Advances in Therapy · doi:10.1007/s12325-019-0870-x · Cited by 126 · see citing works
Green, A. J., Fox, K., & Grandy, S. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.01.002 · Cited by 124 · see citing works
The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach
Pozzilli, P., Leslie, R. D., Chan, J. C. N., Fronzo, R. D., Monnier, L., Raz, I., & Prato, S. D. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1092 · Cited by 114 · see citing works
Williams, S. A., Pollack, M. F., & DiBonaventura, M. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.12.027 · Cited by 102 · see citing works
Glycemic Control and Extended Hemodialysis Survival in Patients with Diabetes Mellitus
Williams, M. E., Lacson, E. K., Jr., Wang, W., Lazarus, J. M., & Hakim, R. M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09301209 · Cited by 98 · see citing works
Zhang, Y., Ting, R. Z. W., Yang, W., Jia, W., Li, W., Ji, L., Guo, X., Kong, A. P. S., Wing, Y. K., Luk, A. O. Y., et al. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12238 · Cited by 96 · see citing works
Lopez, J., Annunziata, K., Bailey, R., Morisky, D. E., & Rupnow, M. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s58813 · Cited by 96 · see citing works
Aung, P. P., Strachan, M. W. J., Frier, B. M., Butcher, I., Deary, I. J., Price, J. F., & on behalf of the Edinburgh Type 2 Diabetes Study Investigators (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03505.x · Cited by 95 · see citing works
Home, P., Fritsche, A., Schinzel, S., & Massi‐Benedetti, M. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01232.x · Cited by 96 · see citing works
Economic and Clinical Impact of Inpatient Diabetic Hypoglycemia
Curkendall, S. M., Natoli, J. L., Alexander, C. M., Nathanson, B. H., Haidar, T., & Dubois, R. W. (2009) · Endocrine Practice · doi:10.4158/ep08343.or · Cited by 95 · see citing works
Zhao, Y., Campbell, C. R., Fonseca, V. A., & Shi, L. (2012) · Diabetes Care · doi:10.2337/dc11-2048 · Cited by 94 · see citing works
Ratzki-Leewing, A., Harris, S. B., Mequanint, S., Reichert, S. M., Belle Brown, J., Black, J. E., & Ryan, B. L. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000503 · Cited by 90 · see citing works
Insulin therapy and quality of life. A review
Pouwer, F., & Hermanns, N. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.981 · Cited by 90 · see citing works
Guidelines for managing diabetes in Ramadan
Ali, S., Davies, M. J., Brady, E. M., Gray, L. J., Khunti, K. K., Beshyah, S., & Hanif, W. (2016) · Diabetic Medicine · doi:10.1111/dme.13080 · Cited by 91 · see citing works
Breitscheidel, L., Stamenitis, S., Dippel, F. W., & Schöffski, O. (2009) · Journal of Medical Economics · doi:10.3111/13696990903479199 · Cited by 90 · see citing works
Glycemic Management in ESRD and Earlier Stages of CKD
Williams, M. E., & Garg, R. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.049 · Cited by 89 · see citing works
Salem, C. B., Fathallah, N., Hmouda, H., & Bouraoui, K. (2010) · Drug Safety · doi:10.2165/11538290-000000000-00000 · Cited by 89 · see citing works
Aravind, S. R., Tayeb, K. A., Ismail, S. B., Shehadeh, N., KADDAHA, G., Liu, R., Balshaw, R. F., Lesnikova, N., Heisel, O., Girman, C. J., et al. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.578245 · Cited by 85 · see citing works
Katon, W. J., Young, B. A., Russo, J. E., Lin, E., Ciechanowski, P. S., Ludman, E. J., & Korff, M. R. V. (2013) · The Annals of Family Medicine · doi:10.1370/afm.1501 · Cited by 84 · see citing works
The risk factors of inpatient hypoglycemia: A systematic review
Pratiwi, C., Mokoagow, M. I., Kshanti, I. A., & Soewondo, P. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03913 · Cited by 83 · see citing works
Ragia, G., Petridis, I., Tavridou, A., Christakidis, D., & Manolopoulos, V. G. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.96 · Cited by 83 · see citing works
Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes
Scheen, A. J. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.05.2659 · Cited by 82 · see citing works
Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan
Devendra, D., Gohel, B., Bravis, V., Hui, E., Salih, S., Mehar, S., & Hassanein, M. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02171.x · Cited by 80 · see citing works
Bron, M., Marynchenko, M. B., Yang, H., Yu, A. P., & Wu, E. Q. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2525 · Cited by 78 · see citing works
Preventing hypoglycaemia: what is the appropriate glucose alert value?
Cryer, P. E. (2009) · Diabetologia · doi:10.1007/s00125-008-1205-7 · Cited by 77 · see citing works
Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes
Barnett, A. H., Cradock, S., Fisher, M., Hall, G., Hughes, E., & Middleton, A. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02332.x · Cited by 75 · see citing works
Singh, A.-K., Patel, P. K., Choudhary, K., Joshi, J., Yadav, D., & Jin, J. (2020) · Biomolecules · doi:10.3390/biom10020207 · Cited by 76 · see citing works
Hypoglycemia, Chronic Kidney Disease, and Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.07.013 · Cited by 76 · see citing works
Walz, L., Pettersson, B., Rosenqvist, U., Deleskog, A., Journath, G., & Wändell, P. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s58781 · Cited by 75 · see citing works
Exercise Therapy in Type 2 Diabetes
van Dijk, J., Tummers, K., Stehouwer, C. D. A., Hartgens, F., & van Loon, L. J. C. (2012) · Diabetes Care · doi:10.2337/dc11-2112 · Cited by 75 · see citing works
Holstein, A., Hammer, C., Hahn, M., Kulamadayil-Heidenreich, N. S. A., & Kovacs, P. L. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2010.492777 · Cited by 74 · see citing works
Hassanein, M., Hanif, W., Malik, W., Kamal, A. D., Geransar, P., Lister, N., Andrews, C., & Barnett, A. H. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.579951 · Cited by 73 · see citing works
Disorders of glucose metabolism: post mortem analyses in forensic cases–part II
Mußhoff, F., Heß, C., & Madea, B. (2010) · International Journal of Legal Medicine · doi:10.1007/s00414-010-0510-0 · Cited by 70 · see citing works
Feldman, S. M., Rosen, R., & DeStasio, J. (2009) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2009.02.010 · Cited by 70 · see citing works
Fear of Hypoglycaemia: Defining a Minimum Clinically Important Difference
Stargardt, T., Gonder-Frederick, L. A., Krobot, K. J., & Alexander, C. M. (2009) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-7-91 · Cited by 69 · see citing works
Zhang, Y., Hong, J., Chi, J., Gu, W., Ning, G., & Wang, W. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2482 · Cited by 67 · see citing works
Alarouj, M., Hassoun, A. A. K., Medlej, R., Pathan, M. F., Shaltout, I., Chawla, M. S., Hristoskova, S., diTommaso, S., & Kadwa, M. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12243 · Cited by 67 · see citing works
Bøgelund, M., Vilsbøll, T., Faber, J., Henriksen, J. E., Gjesing, R. P., & Lammert, M. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.625404 · Cited by 66 · see citing works
Davidson, J. A., Liebl, A., Christiansen, J. S., Fulcher, G., Ligthelm, R. J., Brown, P., Gylvin, T., & Kawamori, R. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.08.011 · Cited by 64 · see citing works
Uncovering undetected hypoglycemic events
Unger, J. (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s29367 · Cited by 62 · see citing works
Bode, B. W., Brett, J., Falahati, A., & Pratley, R. E. (2011) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2011.09.007 · Cited by 62 · see citing works
Is hypoglycemia fear independently associated with health-related quality of life?
Shi, L., Shao, H., Zhao, Y., & Thomas, N. A. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0167-3 · Cited by 62 · see citing works
Barnett, A. H., Patel, S., Harper, R., Toorawa, R., Thiemann, S., von Eynatten, M., & Woerle, H. (2012) · Diabetes, obesity and metabolism · doi:10.1111/dom.12011 · Cited by 67 · see citing works
Disorders of glucose metabolism–post mortem analyses in forensic cases: part I
Heß, C., Mußhoff, F., & Madea, B. (2010) · International Journal of Legal Medicine · doi:10.1007/s00414-010-0509-6 · Cited by 61 · see citing works
Bloomfield, H. E., Greer, N. L., Newman, D. R., MacDonald, R. H., Carlyle, M. H., FITZGERALD, P. J., Rutks, I. R., & Wilt, T. J. (2012) · Cited by 59 · see citing works
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials
Coppolino, G., Leporini, C., Rivoli, L., Ursini, F., Paola, E. D. D., Cernaro, V., Arturi, F., Bolignano, D., Russo, E., Sarro, G. D., et al. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.001 · Cited by 60 · see citing works
Hajós, T. R. S., Polonsky, W. H., Pouwer, F., Gonder-Frederick, L., & Snoek, F. J. (2014) · Diabetes Care · doi:10.2337/dc13-0971 · Cited by 58 · see citing works
Holstein, A., Hahn, M., Patzer, O. M., Seeringer, A., Kovacs, P. L., & Stingl, J. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0976-1 · Cited by 59 · see citing works
Having diabetes and having to fast: a qualitative study of British Muslims with diabetes
Patel, N. R., Kennedy, A. P., Blickem, C., Rogers, A. E., Reeves, D., & Chew-Graham, C. A. (2014) · Health Expectations · doi:10.1111/hex.12163 · Cited by 58 · see citing works
Optimal therapy of type 2 diabetes: a controversial challenge
Dardano, A., Penno, G., Prato, S. D., & Miccoli, R. (2014) · Aging · doi:10.18632/aging.100646 · Cited by 57 · see citing works
The characteristic of cognitive function in Type 2 diabetes mellitus
Gao, Y., Xiao, Y., Miao, R., Zhao, J., Zhang, W., Huang, G., & Ma, F. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.019 · Cited by 56 · see citing works
Bacchi, E., Negri, C., Trombetta, M., Zanolin, M. E., Lanza, M., Bonora, E., & Moghetti, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049937 · Cited by 55 · see citing works
Liraglutide in clinical practice: dosing, safety and efficacy: Liraglutide in practice
Peterson, G. E., & Pollom, R. D. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02498.x · Cited by 55 · see citing works
Willis, W. D., Diago, J. I., Madec-Hily, A., & Aslam, A. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.12.80 · Cited by 54 · see citing works
Sheu, W. H., Ji, L.-N., Nitiyanant, W., Baik, S. H., Yin, D., Mavros, P., & Chan, S.-P. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.027 · Cited by 55 · see citing works
Bruderer, S. G., Bodmer, M., Jick, S. S., Bader, G., Schlienger, R. G., & Meier, C. R. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12282 · Cited by 53 · see citing works
Swinnen, S. G. H. A., Mullins, P., Miller, M., Hoekstra, J. B. L., & Holleman, F. (2009) · Diabetologia · doi:10.1007/s00125-008-1147-0 · Cited by 52 · see citing works
Dementia in Diabetes: The Role of Hypoglycemia
Husain, K. H., Sarhan, S. F., AlKhalifa, H. K. A. A., Buhasan, A., Moin, A. S. M., & Butler, A. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129846 · Cited by 52 · see citing works
McEwan, P., Evans, M., & Bergenheim, K. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01198.x · Cited by 51 · see citing works
Borzı̀, V., Frasson, S., Gussoni, G., Lillo, M., Gerloni, R., Augello, G., Gulli, G., Ceriello, A., Solerte, B., Bonizzoni, E., et al. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.01.020 · Cited by 50 · see citing works
Hypoglycaemia when adding sulphonylurea to metformin: a systematic review and network meta‐analysis
Andersen, S. E., & Christensen, M. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13059 · Cited by 50 · see citing works
Lukashevich, V., Schweizer, A., Foley, J. E., Dickinson, Groop, P., & Kothny, W. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s39300 · Cited by 50 · see citing works
Morton, J. I., Ilomäki, J., Magliano, D. J., & Shaw, J. E. (2020) · Diabetologia · doi:10.1007/s00125-020-05304-3 · Cited by 50 · see citing works
Evolution and resolution of human brain perfusion responses to the stress of induced hypoglycemia
Teh, M. M., Dunn, J., Choudhary, P., Samarasinghe, Y. P., Macdonald, I. A., O'Doherty, M. J., Marsden, P. K., Reed, L. J., & Amiel, S. A. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.033 · Cited by 49 · see citing works
Self-citationDavis, T. M. E. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12295 · Cited by 49 · see citing works
Economic impact of hypoglycemia on healthcare in Spain
Brito-Sanfiel, M. Á., Diago, J. I., & Calderón, A. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.73 · Cited by 48 · see citing works
- Authors
- Amiel, S. A., Dixon, T., Mann, R., & Jameson, K.
- Affiliations
- King's College London (GB)
- University of Sheffield (GB)
- MSD (UK) Limited (United Kingdom) (GB)
- Corresponding author
- Amiel, S. A.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2008-02-27
- Volume
- 25
- Issue
- 3
- Pages
- 245-254
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- PMC
- PMC2327221
- OpenAlex
- W2156888511
- Cited by
- 472
- References
- 77
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 10 · 2023: 11 · 2022: 15 · 2021: 14 · 2020: 15 · 2019: 22 · 2018: 34 · 2017: 17 · 2016: 29 · 2015: 33 · 2014: 46 · 2013: 55 · 2012: 46
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetic Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Health Professions › Emergency Medical Services › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, type 2 diabetes, sulfonylureas, insulin therapy, severe hypoglycemia, glycemic control, incretin-based therapy, hospital costs, diabetes complications
- MeSH terms
- Diabetes Mellitus, Type 2, Hospitalization, Humans, Hypoglycemia, Insulin, Risk Factors, Sulfonylurea Compounds, Antidiuretic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
